Catalyst Pharmaceuticals Inc (CPRX)
21.69
-1.11
(-4.87%)
USD |
NASDAQ |
Nov 14, 16:00
21.55
-0.14
(-0.65%)
After-Hours: 20:00
Catalyst Pharmaceuticals Free Cash Flow (Quarterly): 72.61M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 72.61M |
| June 30, 2024 | 64.12M |
| March 31, 2024 | 31.73M |
| December 31, 2023 | 53.33M |
| September 30, 2023 | -34.22M |
| June 30, 2023 | 30.75M |
| March 31, 2023 | 12.00M |
| December 31, 2022 | 40.08M |
| September 30, 2022 | 41.30M |
| June 30, 2022 | 26.16M |
| March 31, 2022 | 8.478M |
| December 31, 2021 | 19.14M |
| September 30, 2021 | 21.64M |
| June 30, 2021 | 15.67M |
| March 31, 2021 | 2.903M |
| December 31, 2020 | 13.10M |
| September 30, 2020 | 11.44M |
| June 30, 2020 | 13.26M |
| March 31, 2020 | 7.213M |
| December 31, 2019 | 12.29M |
| September 30, 2019 | 16.26M |
| June 30, 2019 | 14.06M |
| March 31, 2019 | -8.022M |
| December 31, 2018 | -8.408M |
| September 30, 2018 | -6.976M |
| Date | Value |
|---|---|
| June 30, 2018 | -4.774M |
| March 31, 2018 | -6.081M |
| December 31, 2017 | -4.030M |
| September 30, 2017 | -2.633M |
| June 30, 2017 | -3.201M |
| March 31, 2017 | -3.879M |
| December 31, 2016 | -4.419M |
| September 30, 2016 | -3.278M |
| June 30, 2016 | -4.432M |
| March 31, 2016 | -5.930M |
| December 31, 2015 | -4.631M |
| September 30, 2015 | -5.358M |
| June 30, 2015 | -4.247M |
| March 31, 2015 | -3.803M |
| December 31, 2014 | -3.994M |
| September 30, 2014 | -3.566M |
| June 30, 2014 | -2.997M |
| March 31, 2014 | -2.442M |
| December 31, 2013 | -4.130M |
| September 30, 2013 | -1.684M |
| June 30, 2013 | -1.812M |
| March 31, 2013 | -2.259M |
| December 31, 2012 | -1.639M |
| September 30, 2012 | -1.101M |
| June 30, 2012 | -1.146M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-34.22M
Minimum
Sep 2023
72.61M
Maximum
Sep 2024
23.15M
Average
17.40M
Median
Free Cash Flow (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 72.19M |
| Sarepta Therapeutics Inc | -107.96M |
| Alnylam Pharmaceuticals Inc | 39.52M |
| Biomarin Pharmaceutical Inc | 200.30M |
| Cytokinetics Inc | -102.20M |